Table 1. Vaccine formulations in each group.
Group | rHspA(μg) | rGGT(μg) | rHspA-GGT(μg) | LTB(μg) | CpG(μg) | Total volume(μl) |
---|---|---|---|---|---|---|
PBS | 0 | 0 | 0 | 0 | 0 | 20 |
CpG | 0 | 0 | 0 | 0 | 10 | 20 |
LTB | 0 | 0 | 0 | 10 | 0 | 20 |
rHspA+LTB | 30 | 0 | 0 | 10 | 0 | 20 |
rGGT+LTB | 0 | 30 | 0 | 10 | 0 | 20 |
rHspA-GGT+LTB | 0 | 0 | 30 | 10 | 0 | 20 |
rHspA-GGT+CpG | 0 | 0 | 30 | 0 | 10 | 20 |
rHspA-GGT | 0 | 0 | 30 | 0 | 0 | 20 |